SECUKINUMAB vs SELADELPAR LYSINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
SECUKINUMAB vs SELADELPAR LYSINE: Safety Overview
| Metric | SECUKINUMAB | SELADELPAR LYSINE |
|---|---|---|
| Total FAERS Reports | 151,223 | 107 |
| Deaths Reported | 6,855 | 1 |
| Death Rate | 4.5% | 0.9% |
| Hospitalizations | 19,098 | 4 |
| Average Patient Age | 52.3 yrs | 61.5 yrs |
| % Female Patients | 61.9% | 94.3% |
| FDA Approval Date | N/A | Aug 14, 2024 |
| Manufacturer | Novartis Pharmaceuticals Corporation | Gilead Sciences, Inc |
| Route | SUBCUTANEOUS | ORAL |
| Marketing Status | Prescription | Prescription |